首页> 外国专利> NOVEL FORMULATION OF CILOSTAZOL, QUINOLINONE DERIVATIVE USED FOR ALLEVIATING SYMPTOM OF INTERMITTENT CLAUDICATION IN PATIENTS WITH PERIPHERAL VASCULAR DISEASE

NOVEL FORMULATION OF CILOSTAZOL, QUINOLINONE DERIVATIVE USED FOR ALLEVIATING SYMPTOM OF INTERMITTENT CLAUDICATION IN PATIENTS WITH PERIPHERAL VASCULAR DISEASE

机译:西洛他唑,喹诺酮衍生物的新配方用于缓解周围血管疾病患者的间歇性闭塞症状

摘要

PROBLEM TO BE SOLVED: To provide extended-release forms of cilostazol pharmaceutical compositions.SOLUTION: A pharmaceutical composition is in solid form containing particulate cilostazol or a salt thereof, a cellulose, a diluent, and a lubricant. The pharmaceutical composition features an in vivo plasma profile for cilostazol of C/C0.25. Also disclosed is a method of preparing the pharmaceutical composition.SELECTED DRAWING: Figure 5
机译:解决的问题:提供西洛他唑药物组合物的缓释形式。解决方案:药物组合物为固体形式,包含颗粒状西洛他唑或其盐,纤维素,稀释剂和润滑剂。该药物组合物的特征在于西洛他唑的体内血浆分布为C / C> 0.25。还公开了制备药物组合物的方法。选图:图5

著录项

  • 公开/公告号JP2016098230A

    专利类型

  • 公开/公告日2016-05-30

    原文格式PDF

  • 申请/专利权人 GENOVATE BIOTECHNOLOGY CO LTD;

    申请/专利号JP20150224682

  • 申请日2015-11-17

  • 分类号A61K31/4709;A61K9/26;A61K47/38;A61K47/02;A61K47/26;A61K47/10;A61K47/36;A61K47/40;A61K47/12;A61K47/14;A61K47/44;A61K47/34;A61P9;A61P7/02;A61P9/08;A61P43;A61K47/20;

  • 国家 JP

  • 入库时间 2022-08-21 14:45:57

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号